| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.043 | 0.4 |